Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sub-type Specific Genomic Mutations in Serous Borderline Ovarian Tumors

NCT03883542 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.

NCT NCT03883542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03883542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sub-type Specific Genomic Mutations in Serous Borderline Ovarian Tumors
Lead sponsor
Universitair Ziekenhuis Brussel
Phase
Observational
Overall status
Active, not recruiting
Start date
January 31, 2017
Completion date
July 30, 2027
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian neoplasm epithelial